Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071.
Saved in:
| Title: | Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071. |
|---|---|
| Authors: | Piperno-Neumann S; Institut Curie, Paris, France. sophie.piperno-neumann@curie.fr., Larkin J; Royal Marsden NHS Foundation Trust, London, United Kingdom., Carvajal RD; Memorial Sloan Kettering Cancer Center, New York, New York., Luke JJ; Dana-Farber Cancer Institute, Boston, Massachusetts., Schwartz GK; Memorial Sloan Kettering Cancer Center, New York, New York., Hodi FS; Dana-Farber Cancer Institute, Boston, Massachusetts., Sablin MP; Institut Curie, Paris, France., Shoushtari AN; Memorial Sloan Kettering Cancer Center, New York, New York., Szpakowski S; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Chowdhury NR; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Brannon AR; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Ramkumar T; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., de Koning L; Institut Curie, Paris, France., Derti A; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Emery C; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Yerramilli-Rao P; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Kapiteijn E; Leiden University Medical Centre, Department of Medical Oncology, Leiden, the Netherlands. |
| Source: | Molecular cancer therapeutics [Mol Cancer Ther] 2020 Apr; Vol. 19 (4), pp. 1031-1039. Date of Electronic Publication: 2020 Feb 06. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32029634 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Piperno-Neumann+S%22">Piperno-Neumann S</searchLink>; Institut Curie, Paris, France. sophie.piperno-neumann@curie.fr.<br /><searchLink fieldCode="AU" term="%22Larkin+J%22">Larkin J</searchLink>; Royal Marsden NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Carvajal+RD%22">Carvajal RD</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Luke+JJ%22">Luke JJ</searchLink>; Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Schwartz+GK%22">Schwartz GK</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Hodi+FS%22">Hodi FS</searchLink>; Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Sablin+MP%22">Sablin MP</searchLink>; Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Shoushtari+AN%22">Shoushtari AN</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Szpakowski+S%22">Szpakowski S</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Chowdhury+NR%22">Chowdhury NR</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Brannon+AR%22">Brannon AR</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ramkumar+T%22">Ramkumar T</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22de+Koning+L%22">de Koning L</searchLink>; Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Derti+A%22">Derti A</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Emery+C%22">Emery C</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Yerramilli-Rao+P%22">Yerramilli-Rao P</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Kapiteijn+E%22">Kapiteijn E</searchLink>; Leiden University Medical Centre, Department of Medical Oncology, Leiden, the Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2020 Apr; Vol. 19 (4), pp. 1031-1039. <i>Date of Electronic Publication: </i>2020 Feb 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32029634 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/1535-7163.MCT-19-0098 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1031 Titles: – TitleFull: Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Piperno-Neumann S – PersonEntity: Name: NameFull: Larkin J – PersonEntity: Name: NameFull: Carvajal RD – PersonEntity: Name: NameFull: Luke JJ – PersonEntity: Name: NameFull: Schwartz GK – PersonEntity: Name: NameFull: Hodi FS – PersonEntity: Name: NameFull: Sablin MP – PersonEntity: Name: NameFull: Shoushtari AN – PersonEntity: Name: NameFull: Szpakowski S – PersonEntity: Name: NameFull: Chowdhury NR – PersonEntity: Name: NameFull: Brannon AR – PersonEntity: Name: NameFull: Ramkumar T – PersonEntity: Name: NameFull: de Koning L – PersonEntity: Name: NameFull: Derti A – PersonEntity: Name: NameFull: Emery C – PersonEntity: Name: NameFull: Yerramilli-Rao P – PersonEntity: Name: NameFull: Kapiteijn E IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2020 Apr Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1538-8514 Numbering: – Type: volume Value: 19 – Type: issue Value: 4 Titles: – TitleFull: Molecular cancer therapeutics Type: main |
| ResultId | 1 |